{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T07:24:19Z","timestamp":1782026659833,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["MUMS 930689"],"award-info":[{"award-number":["MUMS 930689"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005013","name":"Academic Center for Education, Culture and Research","doi-asserted-by":"publisher","award":["ACECR 2262-20"],"award-info":[{"award-number":["ACECR 2262-20"]}],"id":[{"id":"10.13039\/501100005013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s13365-020-00832-5","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T14:02:51Z","timestamp":1586354571000},"page":"338-346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The IL-18, IL-12, and IFN-\u03b3 expression in HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) patients, HTLV-1 carriers, and healthy subjects"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0204-0351","authenticated-orcid":false,"given":"Hamid Reza","family":"Bidkhori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9133-5006","authenticated-orcid":false,"given":"Mohammad Reza","family":"Hedayati-Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8408-4664","authenticated-orcid":false,"given":"Arman","family":"Mosavat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4254-7314","authenticated-orcid":false,"given":"Narges","family":"Valizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Tadayon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9050-9016","authenticated-orcid":false,"given":"Sanaz","family":"Ahmadi Ghezeldasht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houshang","family":"Rafatpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6814-5992","authenticated-orcid":false,"given":"Seyed Abdolrahim","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,8]]},"reference":[{"key":"832_CR1","first-page":"179","volume":"16","author":"S Ahmadi Ghezeldasht","year":"2013","unstructured":"Ahmadi Ghezeldasht S, Shirdel A, Assarehzadegan MA, Hassannia T, Rahimi H, Miri R, Rezaee SA (2013) Human T lymphotropic virus type I (HTLV-I) oncogenesis: molecular aspects of virus and host interactions in pathogenesis of adult T cell leukemia\/lymphoma (ATL). Iran J Basic Med Sci 16:179\u2013195","journal-title":"Iran J Basic Med Sci"},{"key":"832_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1006\/jtbi.2000.2156","volume":"207","author":"B Asquith","year":"2000","unstructured":"Asquith B, Bangham CR (2000) The role of cytotoxic T lymphocytes in human T-cell lymphotropic virus type 1 infection. J Theor Biol 207:65\u201379. https:\/\/doi.org\/10.1006\/jtbi.2000.2156","journal-title":"J Theor Biol"},{"key":"832_CR3","doi-asserted-by":"publisher","first-page":"e0005285","DOI":"10.1371\/journal.pntd.0005285","volume":"11","author":"M Baratella","year":"2017","unstructured":"Baratella M, Forlani G, Raval GU, Tedeschi A, Gout O, Gessain A, Tosi G, Accolla RS (2017) Cytoplasmic localization of HTLV-1 HBZ protein: a biomarker of HTLV-1-associated myelopathy\/tropical spastic Paraparesis (HAM\/TSP). PLoS Negl Trop Dis 11:e0005285. https:\/\/doi.org\/10.1371\/journal.pntd.0005285","journal-title":"PLoS Negl Trop Dis"},{"key":"832_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0042-6822(02)00091-0","volume":"308","author":"K Barmak","year":"2003","unstructured":"Barmak K, Harhaj E, Grant C, Alefantis T, Wigdahl B (2003) Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration. Virology 308:1\u201312. https:\/\/doi.org\/10.1016\/s0042-6822(02)00091-0","journal-title":"Virology"},{"key":"832_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1365-2249.2006.03208.x","volume":"146","author":"I Best","year":"2006","unstructured":"Best I, Adaui V, Verdonck K, Gonzalez E, Tipismana M, Clark D, Gotuzzo E, Vanham G (2006) Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Peru. Clin Exp Immunol 146:226\u2013233","journal-title":"Clin Exp Immunol"},{"key":"832_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cytogfr.2007.04.003","volume":"18","author":"K Brandt","year":"2007","unstructured":"Brandt K, Singh PB, Bulfone-Paus S, Ruckert R (2007) Interleukin-21: a new modulator of immunity, infection, and cancer. Cytokine Growth Factor Rev 18:223\u2013232. https:\/\/doi.org\/10.1016\/j.cytogfr.2007.04.003","journal-title":"Cytokine Growth Factor Rev"},{"key":"832_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/biof.6","volume":"35","author":"V Fensterl","year":"2009","unstructured":"Fensterl V, Sen GC (2009) Interferons and viral infections. Biofactors 35:14\u201320. https:\/\/doi.org\/10.1002\/biof.6","journal-title":"Biofactors"},{"key":"832_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/s0022-510x(02)00016-3","volume":"196","author":"T Fujimoto","year":"2002","unstructured":"Fujimoto T, Nakamura T, Nishiura Y, Ichinose K, Furuya T, Shirabe S, Eguchi K (2002) Up-regulation of interleukin-12 receptor expression in peripheral blood mononuclear cells of patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Neurol Sci 196:21\u201326. https:\/\/doi.org\/10.1016\/s0022-510x(02)00016-3","journal-title":"J Neurol Sci"},{"key":"832_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2169\/internalmedicine.46.6118","volume":"46","author":"N Fukushima","year":"2007","unstructured":"Fukushima N, Nishiura Y, Nakamura T, Kohno S, Eguchi K (2007) Blockade of IL-2 receptor suppresses HTLV-I and IFN-\u03b3 expression in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis. Intern Med 46:347\u2013351","journal-title":"Intern Med"},{"key":"832_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/s0165-5728(98)00263-x","volume":"95","author":"T Furuya","year":"1999","unstructured":"Furuya T, Nakamura T, Fujimoto T, Nakane S, Kambara C, Shirabe S, Hamasaki S, Motomura M, Eguchi K (1999) Elevated levels of interleukin-12 and interferon-gamma in patients with human T lymphotropic virus type I-associated myelopathy. J Neuroimmunol 95:185\u2013189. https:\/\/doi.org\/10.1016\/s0165-5728(98)00263-x","journal-title":"J Neuroimmunol"},{"key":"832_CR11","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4049\/jimmunol.172.3.1735","volume":"172","author":"PK Goon","year":"2004","unstructured":"Goon PK, Igakura T, Hanon E, Mosley AJ, Barfield A, Barnard AL, Kaftantzi L, Tanaka Y, Taylor GP, Weber JN, Bangham CR (2004) Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I. J Immunol 172:1735\u20131743. https:\/\/doi.org\/10.4049\/jimmunol.172.3.1735","journal-title":"J Immunol"},{"key":"832_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1128\/JVI.73.2.1205-1212.1999","volume":"73","author":"KG Hadlock","year":"1999","unstructured":"Hadlock KG, Rowe J, Foung SK (1999) The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes. J Virol 73:1205\u20131212","journal-title":"J Virol"},{"key":"832_CR13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.virol.2006.11.028","volume":"361","author":"JM Heraud","year":"2007","unstructured":"Heraud JM, Merien F, Mortreux F, Mahieux R, Kazanji M (2007) Immunological changes and cytokine gene expression during primary infection with human T-cell leukaemia virus type 1 in squirrel monkeys (Saimiri sciureus). Virology 361:402\u2013411. https:\/\/doi.org\/10.1016\/j.virol.2006.11.028","journal-title":"Virology"},{"key":"832_CR14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1086\/650314","volume":"201","author":"A Iannello","year":"2010","unstructured":"Iannello A, Boulassel MR, Samarani S, Tremblay C, Toma E, Routy JP, Ahmad A (2010) HIV-1 causes an imbalance in the production of interleukin-18 and its natural antagonist in HIV-infected individuals: implications for enhanced viral replication. J Infect Dis 201:608\u2013617. https:\/\/doi.org\/10.1086\/650314","journal-title":"J Infect Dis"},{"key":"832_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3844\/ajidsp.2009.231.258","volume":"5","author":"BP Irish","year":"2009","unstructured":"Irish BP, Khan ZK, Jain P, Nonnemacher MR, Pirrone V, Rahman S, Rajagopalan N, Suchitra JB, Mostoller K, Wigdahl B (2009) Molecular mechanisms of neurodegenerative diseases induced by human retroviruses: a review. Am J Infect Dis 5:231\u2013258. https:\/\/doi.org\/10.3844\/ajidsp.2009.231.258","journal-title":"Am J Infect Dis"},{"key":"832_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1046\/j.1365-2249.2000.01284.x","volume":"121","author":"D Lammas","year":"2000","unstructured":"Lammas D, Casanova JL, Kumararatne D (2000) Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-\u03b3) pathway. Clin Exp Immunol 121:417\u2013425","journal-title":"Clin Exp Immunol"},{"key":"832_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-3083.2009.02291.x","volume":"70","author":"P Montanheiro","year":"2009","unstructured":"Montanheiro P, Penalva de Oliveira A, Smid J, Fukumori L, Olah I, Duarte AS, Casseb J (2009) The elevated interferon gamma production is an important immunological marker in HAM\/TSP pathogenesis. Scand J Immunol 70:403\u2013407","journal-title":"Scand J Immunol"},{"key":"832_CR18","doi-asserted-by":"publisher","first-page":"e19879","DOI":"10.5812\/hepatmon.19879","volume":"14","author":"M Motavaf","year":"2014","unstructured":"Motavaf M, Safari S, Alavian SM (2014) Interleukin 18 gene promoter polymorphisms and susceptibility to chronic hepatitis B infection: a review study. Hepat Mon 14:e19879. https:\/\/doi.org\/10.5812\/hepatmon.19879","journal-title":"Hepat Mon"},{"key":"832_CR19","first-page":"329","volume":"4","author":"S Park","year":"2007","unstructured":"Park S, Cheon S, Cho D (2007) The dual effects of interleukin-18 in tumor progression. Cell Mol Immunol 4:329\u2013335","journal-title":"Cell Mol Immunol"},{"key":"832_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.0504\/ijaai.153166","volume":"5","author":"H Rafatpanah","year":"2006","unstructured":"Rafatpanah H, Farid R, Golanbar G, Jabbari Azad F (2006) HTLV-I infection: virus structure, immune response to the virus and genetic association studies in HTLV-I-infected individuals. Iran J Allergy Asthma Immunol 5:153\u2013166. https:\/\/doi.org\/10.0504\/ijaai.153166","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"832_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcv.2011.07.004","volume":"52","author":"H Rafatpanah","year":"2011","unstructured":"Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, Sohgandi L, Azarpazhooh MR, Rezaee SA, Farid R, Bazarbachi A (2011) High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol 52:172\u2013176. https:\/\/doi.org\/10.1016\/j.jcv.2011.07.004","journal-title":"J Clin Virol"},{"key":"832_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2012.05.004","volume":"250","author":"H Rafatpanah","year":"2012","unstructured":"Rafatpanah H, Rezaee A, Etemadi MM, Hosseini RF, Khorram B, Afsahr L, Taylor G, Mokhber N, Mahmoudi M, Abbaszadegan MR, Foroghipor M, Hashemi P, Amiri A, Tehrani M, Azarpazhooh A, Azarpazhooh MR (2012) The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran. J Neuroimmunol 250:87\u201393. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.05.004","journal-title":"J Neuroimmunol"},{"key":"832_CR23","first-page":"143","volume":"80","author":"MC Rocha-J\u00fanior","year":"2012","unstructured":"Rocha-J\u00fanior MC, Haddad R, Ciliao Alves D, de Deus WV, Mendes-Junior CT, Deghaide N, Takayanagui OM, Covas DT, Donadi EA, Kashima S (2012) Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection. HLA 80:143\u2013150","journal-title":"HLA"},{"key":"832_CR24","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1086\/511435","volume":"195","author":"CA Sailer","year":"2007","unstructured":"Sailer CA, Pott GB, Dinarello CA, Whinney SM, Forster JE, Larson-Duran JK, Landay A, Al-Harthi L, Schooley RT, Benson CA (2007) Whole-blood interleukin-18 level during early HIV-1 infection is associated with reduced CXCR4 coreceptor expression and interferon-\u03b3 levels. J Infect Dis 195:734\u2013738","journal-title":"J Infect Dis"},{"key":"832_CR25","doi-asserted-by":"crossref","unstructured":"Saito M (2010) Immunogenetics and the pathological mechanisms of human T-cell leukemia virus type 1-(HTLV-1-) associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Interdisc Perspect Infect Dis 2010","DOI":"10.1155\/2010\/478461"},{"key":"832_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-4690-6-19","volume":"6","author":"M Saito","year":"2009","unstructured":"Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K, Matsuoka M, Ohara Y (2009) In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Retrovirology 6:19. https:\/\/doi.org\/10.1186\/1742-4690-6-19","journal-title":"Retrovirology"},{"key":"832_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.actatropica.2012.09.012","volume":"125","author":"ALB Starling","year":"2013","unstructured":"Starling ALB, Martins-Filho OA, Lambertucci JR, Labanca L, de Souza Pereira SR, Teixeira-Carvalho A, Martins ML, Ribas JG, Carneiro-Proietti ABF, Gon\u00e7alves DU (2013) Proviral load and the balance of serum cytocines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Acta Trop 125:75\u201381","journal-title":"Acta Trop"},{"key":"832_CR28","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1046\/j.1365-2249.2003.02179.x","volume":"132","author":"E Stylianou","year":"2003","unstructured":"Stylianou E, Bjerkeli V, Yndestad A, Heggelund L, Waehre T, Dam\u00e5s J, Aukrust P, Fr\u00f8land S (2003) Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients. Clin Exp Immunol 132:462\u2013466","journal-title":"Clin Exp Immunol"},{"key":"832_CR29","doi-asserted-by":"publisher","first-page":"e1002480","DOI":"10.1371\/journal.ppat.1002480","volume":"8","author":"S Tattermusch","year":"2012","unstructured":"Tattermusch S, Skinner JA, Chaussabel D, Banchereau J, Berry MP, McNab FW, O\u2019Garra A, Taylor GP, Bangham CR (2012) Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLoS Pathog 8:e1002480. https:\/\/doi.org\/10.1371\/journal.ppat.1002480","journal-title":"PLoS Pathog"},{"key":"832_CR30","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.micinf.2004.07.009","volume":"6","author":"A Wiercinska-Drapalo","year":"2004","unstructured":"Wiercinska-Drapalo A, Jaroszewicz J, Flisiak R, Prokopowicz D (2004) Plasma interleukin-18 is associated with viral load and disease progression in HIV-1-infected patients. Microbes Infect 6:1273\u20131277","journal-title":"Microbes Infect"},{"key":"832_CR31","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.4049\/jimmunol.161.7.3400","volume":"161","author":"T Yoshimoto","year":"1998","unstructured":"Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S-I, Okamura H, Akira S, Nakanishi K (1998) IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-\u03b3 production. J Immunol 161:3400\u20133407","journal-title":"J Immunol"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-020-00832-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-020-00832-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-020-00832-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T18:06:56Z","timestamp":1696010816000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-020-00832-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,8]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["832"],"URL":"https:\/\/doi.org\/10.1007\/s13365-020-00832-5","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,8]]},"assertion":[{"value":"26 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"This study was reviewed, approved, and supervised by the Research Ethics Committee of Mashhad University of Medical Sciences (IR.MUMS.REC.930689). Informed consent was obtained and signed by all subjects who participated in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}